Blog

blog image

Leveraging Next Best Triggers to Transform HCP Engagement in Oncology

In the dynamic and data-driven field of oncology, effectively engaging healthcare professionals (HCPs) is essential for success. Emerging biopharma companies face unique challenges, including narrow drug labels and complex treatment pathways. To navigate this landscape, Next Best Action (NBA) strategies present a powerful approach, enabling personalized and timely engagement with HCPs. This blog outlines how oncology teams

Read More
blog image

Leveraging ‘Predictive  Analytics to support Oncology Patient Journeys’

The oncology landscape is rapidly changing, with a significant surge in the number of approved therapies. In the past five years alone, 60+ new oncology drugs have been launched, intensifying competition among biopharmaceutical companies to effectively identify and engage specific patient segments that could benefit from these treatments. However, the challenge remains: how can companies

Read More
blog image

Planning commercial success for an upcoming specialty drug launch in 2025

As the pharmaceutical landscape continues to evolve, launching a new specialty drug in 2025 presents both unique opportunities and significant challenges. The rapid growth in specialty medications, particularly in areas like cell and gene therapies, requires commercial technology and analytics leaders to adopt a strategic approach that leverages data-driven insights and innovative engagement tactics. Understanding

Read More
blog image

The Future of Drug Discovery: How Technology is Changing the Game

Drug discovery is a protracted and resource-intensive endeavor, typically requiring a decade or more and substantial financial investment to bring a single novel therapeutic to market. However, the emergence of innovative technologies presents a transformative potential for accelerating and optimizing this process. Artificial intelligence (AI) stands as a prominent example, offering powerful capabilities in drug

Read More